Royalty Pharma Targetkan Penerimaan Portofolio 2026 Sebesar $3,4 Miliar - $3,5 Miliar Seiring Kenaikan Panduan Sekali Lagi (NASDAQ:RPRX)
· seekingalpha.com
Panggilan laba Q2 2026 Royalty Pharma (RPRX): menaikkan panduan, arus kas kuat, $1,1 Miliar dikerahkan termasuk.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...